IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 113 filers reported holding IGM BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 4.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $9,779,816 | -31.0% | 711,777 | -14.6% | 0.02% | -60.0% |
Q4 2022 | $14,173,430 | -35.2% | 833,241 | -13.3% | 0.06% | -22.5% |
Q3 2022 | $21,867,000 | +17.3% | 961,613 | -7.0% | 0.07% | +42.0% |
Q2 2022 | $18,644,000 | -32.5% | 1,034,035 | 0.0% | 0.05% | -9.1% |
Q1 2022 | $27,639,000 | +0.4% | 1,034,035 | +10.1% | 0.06% | +7.8% |
Q4 2021 | $27,542,000 | -55.9% | 939,035 | -1.0% | 0.05% | -51.4% |
Q3 2021 | $62,393,000 | -28.7% | 948,797 | -9.8% | 0.10% | -18.6% |
Q2 2021 | $87,479,000 | +8.3% | 1,051,429 | -0.2% | 0.13% | +7.5% |
Q1 2021 | $80,797,000 | -12.9% | 1,053,552 | +0.2% | 0.12% | -20.5% |
Q4 2020 | $92,792,000 | +35.4% | 1,050,984 | +13.2% | 0.15% | +18.9% |
Q3 2020 | $68,555,000 | +24.6% | 928,800 | +23.2% | 0.13% | -8.6% |
Q2 2020 | $55,028,000 | +102.7% | 753,800 | +55.9% | 0.14% | +19.8% |
Q1 2020 | $27,154,000 | – | 483,600 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
RA Capital Management | 937,500 | $7,828,125 | 0.15% |
Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |